As a Data Scientist at J&B Medical Supply, you will sit at the intersection of complex healthcare logistics and advanced data analytics. Your work is fundamental to optimizing the distribution of medical supplies, ensuring that patients receive critical equipment efficiently and reliably. By leveraging large datasets, you will directly influence supply chain operations, inventory management, and customer experience, turning raw data into actionable business intelligence.
This role is both challenging and rewarding, requiring you to bridge the gap between technical rigor and practical business outcomes. You will collaborate with cross-functional teams, including operations, product, and leadership, to solve high-impact problems that directly affect the lives of patients and the profitability of the organization. If you are passionate about applying machine learning and statistical modeling to real-world, high-stakes supply chain environments, this position offers a significant opportunity to drive strategic change.
High-Level Screening
reportedAn added round often puts you in front of someone outside the core hiring team: a partner engineer, a product owner, a domain expert, sometimes a more senior manager. The question they are really asking is not whether you can do the work but whether they would trust a number that came from you. That changes what a good answer looks like. Lead with what the decision cost and what it changed, keep the method available but not central, and be plain about the limits of your evidence. Overstating a result is the fastest way to lose this round.
What to demonstrate
- Whether you can explain a technical choice to someone who will never read your code, without either flattening it into nothing or hiding inside jargon
- Honesty about evidence strength: what the analysis establishes, what it only suggests, and what it cannot say at all
- How you take disagreement, specifically whether you update on a good objection, hold your position with reasons, or fold on contact
How to prepare
- Write the two-sentence version of your most technical project for a non-specialist, then check that neither sentence needs a method name to make sense.
- For one result you are proud of, write the strongest objection someone could raise and a response that concedes the part of it that is correct.
- Prepare one decision that turned out to be wrong: how you found out, what it cost, and what you changed afterwards. A senior cross-functional interviewer asks for this more often than a technical one does.
Technical Conversations
reportedA handful of shapes account for most of what gets asked in this format: a ranking or deduplication inside groups, a running or rolling total, a period-over-period comparison, and a cohort tracked forward over time. Recognising the shape quickly is most of the speed here; deriving it from scratch while a clock runs is where the time goes. Know that a window function keeps every row while a GROUP BY collapses them, and know which one the question needs. If the exercise is in Python instead of SQL, the same shapes arrive as groupby with transform, shift and merge, and the same grain mistakes are available.
What to demonstrate
- Whether you reach the right construct without a detour, such as ROW_NUMBER over a partition to deduplicate instead of a self-join against a MAX subquery
- Whether you know what your window frame actually is, since adding ORDER BY inside OVER changes the default frame and silently changes a running total
- Whether the thing runs. A near-miss that throws an error scores below a plainer query that returns the right rows.
How to prepare
- Write each of the four shapes once from memory against a small schema and keep the working version somewhere you will reread it: dedupe with ROW_NUMBER, a running total, a month-over-month change with LAG, and a retention table
- Compute one running total twice on data with tied timestamps, once on the default frame and once with ROWS BETWEEN UNBOUNDED PRECEDING AND CURRENT ROW, and look at where the two disagree
- If Python is on the table, rebuild the dedupe and the running total with groupby and cumsum, then assert the two implementations return identical rows
Leadership Assessment
reportedThis round decides whether someone can hand you a schema and a question and trust the number that comes back. Correctness under a clock is the bar, not clever syntax. The habit that separates strong from weak answers is checking the grain: after every join, know how many rows you expect and whether the count moved. Most wrong answers in this format are not wrong logic, they are a fan-out from a key that turned out not to be unique, or a filter applied before an aggregate when it belonged after. Say what you expect before you run it.
What to demonstrate
- Whether your row counts survive each join, and whether you notice on your own when they do not
- Deliberate handling of rows that fail to match, including whether the question needs an inner join or a left join with the non-matches kept and counted
- Whether NULLs are treated on purpose, given that a NULL compares equal to nothing and that COUNT of a column skips it
- Reaching a defensible answer inside the window instead of a refined one after it
How to prepare
- Take a two-table schema, write a join that fans out on purpose, then fix it by collapsing the many-side to one row per key before joining. Repeat until the fix is reflex rather than recall.
- Write a funnel as one query and print the distinct user count at each stage, then confirm each stage is a subset of the one above it rather than assuming it
- Do a few timed runs in a plain text box with no autocomplete and no formatter, since assessment editors often have neither
Case Studies
reportedThis round runs as a working session, so part of what it decides is whether you are useful to think with. The interviewer will interrupt: a hint that the data you assumed does not exist, a challenge to your metric, a nudge toward a branch you skipped. Treating those as interference is the common failure. Reason out loud while your thinking is still provisional so there is something to react to, and when a redirect arrives, take it instead of defending the path you had already started down.
What to demonstrate
- Whether your reasoning is audible while it is still unsettled, or only after you have privately decided
- What you do with a hint: absorb it and adjust, or argue for the original route
- Whether your clarifying questions have answers that would change your approach, as opposed to filling silence
- Whether you can be wrong about something in the middle of the case and keep moving without restarting
How to prepare
- Run practice cases with a partner instructed to interrupt twice: once to remove a data source you assumed existed, once to reject the metric you chose. Practise absorbing both without going back to the start.
- Before each practice case, write down the clarifying questions you plan to ask, then check afterwards whether any answer actually changed what you did. Drop the ones that did not.
- Explain an analysis you already know well to someone outside the field and have them stop you at every point where the reasoning jumped a step.
Coding Sessions
reportedMuch of what gets scored here happens out loud while you type. Nobody can see your reasoning inside a half-written query, so five silent minutes read as being stuck even when they are not. State the plan in plain language first: which tables, what grain you are aggregating to, and the one filter that defines the population. Then write it. The narration doubles as insurance, because a wrong plan gets caught early and cheaply while a wrong query gets caught at the end with no time left to redo it. A timed statistics section, where one exists, is a separate test with its own clock.
What to demonstrate
- Whether the query you write matches the plan you just described
- What you do with a hint, meaning whether the correction gets absorbed or the first approach gets defended
- Whether you can debug your own wrong output by reading the result set and naming which part of the query produced the anomaly
How to prepare
- Solve three problems while screen-sharing into a recording, then watch it back and mark every stretch longer than thirty seconds where you said nothing
- Practise compressing the plan into one sentence before typing, then check afterwards whether the finished query actually matched it
- Time yourself on statistics questions that carry a business reading, such as what a confidence interval does and does not claim, rather than re-reading notes without a clock
Panel Interviews
reportedWhere a loop includes a partner from outside the data team, that conversation usually carries the same weight as the technical ones and gets the least preparation. The person opposite you will not follow a derivation and does not need to. They are working out whether having you involved would make their decisions better or slower. The failure mode is not being too technical. It is answering a question about a decision with a description of your method, leaving the translation to them. What they carry into the debrief is the sentence you handed them, not the analysis underneath it.
What to demonstrate
- Whether a statistical result arrives as something the partner could act on, with the one caveat that would change their decision kept and the rest left out
- Whether you can state what you need from their side, in their terms: instrumentation that does not exist yet, a definition they own, or a holdout they have to agree to
- Whether uncertainty is given as a range someone can plan against, rather than as hedging that invites them to ignore the result
- Whether you ask what decision is actually on the table before explaining anything
How to prepare
- Take a result you know well and write the version for someone who stops reading after one sentence, then the three-minute version, and check the short one is not the long one with the qualifications stripped out
- For a past project, list everything you asked a non-technical partner for and how you phrased it, then rewrite each ask so it names what goes unmeasured without it
- Practise saying where a result does not apply, out loud, in one sentence that a partner could repeat accurately to someone else
PracHub editorial advice for the preparation topics above.
Pre-post evaluation on a high-cost or high-risk cohort
Cohorts selected on an extreme value of the outcome regress toward the mean on their own. Members identified as the top 1 percent of spend in one year spend far less the next, whether or not anyone intervenes, because the selecting year captured both chronic severity and one-off events. A pre-post design on such a cohort will report savings every time. A concurrent comparison group selected by the same rule in the same period, or a regression discontinuity at the selection threshold, is the minimum credible design.
Reading the most recent months of a claims-based series as real
Claims incur before they are reported and paid, so recent incurred months are systematically undercounted until runout completes. The lag is not uniform: pharmacy adjudicates in days, professional claims in weeks, inpatient facility claims in months. That means recent data is both too low and mix-shifted toward cheap services, which reads as a cost improvement and a utilisation drop at once. The fix is to hold the last three incurred months back or apply completion factors, and to state the paid-through date on every chart.
Over-explaining the method and under-explaining the implication
Lead with the answer and what you would do about it, then give the approach when asked. Roughly one sentence of method per three of implication is the right ratio for a stakeholder-facing answer; the interviewer already knows what a regression is.
Reporting a p-value with no effect size or interval
Give the estimated difference with a confidence interval in the units the business cares about, then say whether that whole interval is worth acting on. A p-value only addresses whether you can rule out exactly zero; it says nothing about magnitude.
Choose a category, try a prompt, then open its approach, worked solution or follow-up when you need it.
Can you discuss a time you had to deal with missing or noisy data in a…
Can you discuss a time you had to deal with missing or noisy data in a large dataset?
Approach
- Quantify uncertainty explicitly rather than reporting a point estimate alone.
- Say what the estimate is of, and over what population it generalises.
- Sanity-check the answer against a simple bound or a simulated case.
Follow-up
- How would you explain this result to someone who does not know statistics?
- What sample size would you need to detect an effect half this size?
What are the common challenges you face when deploying machine learnin…
What are the common challenges you face when deploying machine learning models into production?
Approach
- Set a baseline first, so any model has something honest to beat.
- Say how the offline result would be validated online before it is trusted.
- Pick an evaluation metric that matches the cost of each error type, not a default.
Follow-up
- What would you monitor after launch to know the model is still valid?
- How would you choose the decision threshold, and who owns that choice?
What statistical methods do you use to validate the significance of yo…
What statistical methods do you use to validate the significance of your model results?
Approach
- Frame the prediction: the label, the moment of prediction, and the action it triggers.
- Pick an evaluation metric that matches the cost of each error type, not a default.
- Set a baseline first, so any model has something honest to beat.
Follow-up
- Where could label leakage enter this setup?
- What would you monitor after launch to know the model is still valid?
Bootstrap a confidence interval for a ratio-of-sums PMPM
You have one row per member for a fully run-out incurred year: member_id, member_months, allowed_amount. Report allowed PMPM, defined as sum(allowed_amount) divided by sum(member_months), with a 95 percent confidence interval from a bootstrap you write yourself. No library resampler. Resample members with replacement, recompute the ratio on each of 2,000 replicates, take a percentile interval, and seed the generator so the result reproduces. In two sentences, state why resampling claim lines instead of members would be wrong.
Approach
- Name the estimator precisely: PMPM is a ratio of sums, not the mean of per-member ratios. The two differ whenever exposure correlates with spend, and it does, because members who churn out mid-year are systematically different from members covered all twelve months.
- Resample the unit of independence, which is the member, and recompute numerator and denominator together on the same draw. Recomputing only the numerator against a fixed denominator understates variance and is a common slip.
- Pull member_months and allowed_amount into numpy arrays once, then draw indices with rng.integers(0, n, size=n) per replicate. Index draws over arrays run one to two orders of magnitude faster than DataFrame.sample, which is the difference between 2,000 replicates and 200.
- Take the 2.5th and 97.5th percentiles of the replicate ratios. Expect an interval that is asymmetric around the point estimate, because healthcare spend is right skewed. That asymmetry is the method working, not a bug to centre away.
- Answer the line-resampling question concretely: the many lines of one high-cost member are not independent draws, so line resampling shrinks the interval toward zero width, and member_months has no line-level analogue, so the denominator becomes undefined.
Worked solution 25 min
- Compute the point estimate as allowed.sum() / months.sum() on the full sample.
- Extract both columns to float numpy arrays and create rng = np.random.default_rng(seed).
- Loop 2,000 times: idx = rng.integers(0, n, n); ratio = allowed[idx].sum() / months[idx].sum(); store it.
- Take np.percentile(replicates, [2.5, 97.5]) and report the point estimate with that interval and the seed.
Follow-up
- Half a percent of members have a transplant or a long NICU stay. Does a percentile interval still have nominal coverage, and what would you do about the tail?
- The question changes to comparing PMPM across provider panels. What becomes the resampling unit and why?
- How would you use the same replicates to test whether this year's PMPM differs from last year's, given the same members appear in both?
Measure ninety-day primary care contact for an enrollment cohort
member_enrollment gives span_id, member_id, product_type, effective_date and termination_date, which is NULL while a span is active. medical_claim_line gives member_id, service_start_date, procedure_code and claim_status. The cohort is members whose earliest 2025 span has effective_date in January 2025 and who stay covered at least 90 days from it. Return, by product_type, cohort size and the share with at least one paid claim line whose procedure_code is in a supplied list of evaluation-and-management office visit codes and whose service_start_date falls in the half-open window from effective_date to effective_date plus 90 days.
Approach
- Build the cohort as one row per member before touching claims. Take the earliest 2025 span per member, require its effective_date in January, and require coverage to effective_date + 90 days, which means termination_date IS NULL OR termination_date >= effective_date + 89.
- Use EXISTS for the numerator rather than a join. A member with four office visits must count once; joining and counting rows inflates the numerator and can push the rate above 1.
- Keep the window half-open and anchored per member. Every member has a different effective_date, so a single fixed calendar window is a different metric and will not match the cohort definition.
- Aggregate numerator and denominator in one pass with a conditional sum grouped by product_type, and carry the raw counts alongside the rate so the reader can see the denominator.
- State the reportability rule on the output: the January cohort is not final until 90 days plus professional-claims runout have passed, so label the paid-through date.
Follow-up
- A member changes plan on day 40, closing one span and opening another. Is she still in the cohort, and which product_type does she report under?
- What moves if denied lines are allowed into the numerator, and which definition is right for an access metric?
- How would you show this as a cumulative curve by day since effective_date instead of one 90-day point?
Reconstruct drug coverage intervals and compute proportion of days covered
pharmacy_claim holds fill_id, member_id, ndc_code, therapeutic_class_code, fill_date, days_supply, reversal_flag and reversed_fill_id. Early refills overlap, so days_supply must be laid end to end: each fill's coverage starts at the later of its fill_date and the previous interval's end. Both rows of a reversed pair are excluded. For one therapeutic_class_code over 2025-01-01 to 2025-06-30, return per member the proportion of days covered, defined as covered days divided by days from first fill_date to window end, plus the share of members at or above 0.80. Require at least two fills and 91 days of follow-up.
Approach
- Clean the fills first. Drop rows with reversal_flag TRUE and also the fills they point at through reversed_fill_id. Dropping only the reversal row leaves an original fill counted as exposure that never reached the member. Use NOT EXISTS for that second step, since reversed_fill_id is nullable and NOT IN would return nothing.
- Shift, never stack. The shifted end is covered_end_i = GREATEST(fill_date_i, covered_end_{i-1}) + days_supply_i, which looks recursive but has a closed form: with cum_i the running sum of days_supply through fill i, covered_end_i = cum_i + MAX over j <= i of (fill_date_j - cum_{j-1}). That is SUM(days_supply) OVER (ORDER BY fill_date ROWS UNBOUNDED PRECEDING) plus a running MAX of an anchor column, so it is two window functions and no recursive CTE.
- Derive covered_start_i as GREATEST(fill_date_i, LAG(covered_end)). The intervals are disjoint by construction, so covered days is a plain sum of lengths and never needs a distinct day grid.
- Clip intervals to the window end before summing, and decide explicitly whether to clip at disenrollment as well. Supply that runs past the window must not inflate the numerator.
- Use the denominator the spec names, first fill_date to window end, and hold it constant across classes. A fixed-window denominator yields a different and usually lower number, and mixing the two across classes makes the comparison meaningless.
- Apply the inclusion rules at member level after the intervals are built, then compute the share at or above 0.80 with the qualifying member count beside it.
Worked solution 40 min
- Filter to the therapeutic_class_code and window, then remove reversal rows and their originals with NOT EXISTS.
- Per member ordered by fill_date, compute cum_supply and anchor = fill_date - (cum_supply - days_supply), then covered_end = cum_supply + MAX(anchor) OVER (ORDER BY fill_date ROWS UNBOUNDED PRECEDING).
- Compute covered_start = GREATEST(fill_date, LAG(covered_end) OVER (ORDER BY fill_date)), clip both ends to the window, and drop intervals that collapse.
- Sum interval lengths as covered_days, compute follow_up_days from first fill_date to window end, and divide.
- Apply the two-fill and 91-day rules, then aggregate the share at or above 0.80.
Follow-up
- A member is hospitalised for twelve days mid-window, when the facility supplies medication. Should those days count as covered, and what do published adherence measures do about them?
- Someone wants to classify adherence over twelve months and then compare mortality from month zero. What is wrong with that design and what fixes it?
- Two different ndc_codes in the same therapeutic class overlap. Is that stacking or switching, and how does your interval logic treat each case?
Given a dataset of customer orders, how would you segment users to opt…
Given a dataset of customer orders, how would you segment users to optimize our marketing spend?
Approach
- Fix the population and the time window before naming any metric.
- Restate the decision this analysis has to support, and who acts on the answer.
- Decompose the metric into the rates that drive it, and say which one you would check first.
Follow-up
- How would you detect that the metric is being gamed rather than genuinely improving?
- What would you do if the primary metric and the guardrail moved in opposite directions?
How would you measure the success of a new patient engagement initiati…
How would you measure the success of a new patient engagement initiative?
Approach
- State what result would change your recommendation, so the answer is falsifiable.
- Fix the population and the time window before naming any metric.
- Restate the decision this analysis has to support, and who acts on the answer.
Follow-up
- Which segment would you cut first, and what would that rule out?
- How would you detect that the metric is being gamed rather than genuinely improving?
How do you prioritize projects when you have multiple competing reques…
How do you prioritize projects when you have multiple competing requests from different departments?
Approach
- Fix the population and the time window before naming any metric.
- State what result would change your recommendation, so the answer is falsifiable.
- Name one primary metric, then the guardrail that stops it being gamed.
Follow-up
- Which segment would you cut first, and what would that rule out?
- How would you detect that the metric is being gamed rather than genuinely improving?
Suppose our shipping costs have increased unexpectedly; how would you …
Suppose our shipping costs have increased unexpectedly; how would you use data to investigate the root cause?
Approach
- State what result would change your recommendation, so the answer is falsifiable.
- Fix the population and the time window before naming any metric.
- Restate the decision this analysis has to support, and who acts on the answer.
Follow-up
- Which segment would you cut first, and what would that rule out?
- What would you do if the primary metric and the guardrail moved in opposite directions?
Plan interim looks and multiplicity control for a year-long trial
A 12-month cluster-randomised care-management trial has one primary endpoint (ambulatory care sensitive admissions per 1,000 member-years), three secondary endpoints, and five pre-specified subgroups. The steering group wants a read every month. At month 2 the primary is nominally significant at p = 0.03 with an effect roughly three times the powered assumption. Write the monitoring and analysis plan that should have been in place, and say precisely what you tell the steering group about month 2.
Approach
- Quantify the peeking cost rather than asserting it. Testing accumulating data repeatedly at a fixed nominal 0.05 raises the overall type I error to roughly 0.14 at five equally spaced looks and roughly 0.19 at ten; a monthly read for a year is worse than either.
- Replace fixed-threshold looks with a Lan-DeMets alpha-spending plan on a pre-specified number of looks. An O'Brien-Fleming spending function is right here because it spends almost nothing early (a first look needs a nominal p on the order of 1e-5) and preserves close to 0.05 for the final analysis; Pocock's constant boundary (about 0.0158 nominal at each of five looks) buys early stopping power at the cost of a stricter final look. Monitor the safety guardrail on a separate, non-binding harm boundary, because stopping for harm is a different decision from stopping for efficacy.
- Control the endpoint family with a gatekeeping structure: test the primary at full alpha, and only on success test the three secondaries in a pre-specified fixed sequence or with Holm. Declare the five subgroups exploratory, test them as treatment-by-subgroup interactions rather than as within-subgroup significance, and report them with FDR control and that label attached.
- Separate the three distinct reasons the month-2 effect is inflated. Alpha inflation from the unplanned look is one. Early-exposure inflation is another, since the first clusters to go live are the enthusiastic ones and their staff are running a new process attentively, which decays as it becomes routine. Claims incompleteness is the third and is specific to this outcome: inpatient facility claims run out over months, so month 2 admission counts are undercounted, and the undercount does not have to be equal across arms.
- Tell the steering group that month 2 is not a result: p = 0.03 is nowhere near any defensible first-look boundary, the recent incurred months are incomplete at the stated paid-through date, and estimates taken at a crossing are conditionally biased upward, so even a real stop would require a bias-adjusted effect estimate rather than the raw one.
Worked solution 40 min
- State the fixed number of interim analyses and the information fractions at which they occur, then pick the spending function and derive nominal boundaries so the total spend equals 0.05.
- Write the gatekeeping rule for the three secondaries and the exploratory label plus FDR rule for the five subgroups.
- Specify that the primary is computed only at a stated paid-through date, with the three most recent incurred months either held back or completion-factored.
- Add an exposure-time analysis: index every cluster on its own go-live date and report the effect by cluster-months since activation, so habituation and staggered rollout are visible rather than pooled away.
- Write the month-2 statement: the boundary was not crossed, the data are incomplete, and no effect estimate will be circulated.
Follow-up
- The steering group insists on monthly visibility. What can you show them every month that does not spend alpha?
- How would you tell a genuine effect apart from an exposure-time artefact when clusters went live on a staggered schedule?
- If the trial does cross an efficacy boundary at month 8, what effect estimate do you publish and why is it not the raw one?
Protocol deviations fell as new sites came online
Protocol deviations per 100 completed visits across a multi-site study fell from 4.6 to 2.9 over two months while randomisation accelerated. study_subject_visit carries study_id, site_id, subject_id, visit_number, visit_name, planned_visit_date, actual_visit_date, visit_window_days, visit_status, protocol_deviation_flag, deviation_severity, data_entry_ts and site_activation_date. Operations wants to credit a retraining rollout that began in that window. Establish whether deviation behaviour changed, and deliver a version of the series that is safe to review monthly.
Approach
- Treat deviation flags as late-arriving data. Build a lag triangle of data_entry_ts minus actual_visit_date, because deviations are largely identified during monitoring review weeks after the visit, so the two most recent months are structurally undercounted in exactly the way an improvement looks.
- Hold back the months that are not developed, or apply development factors fitted on fully developed months, and restate. Do this before any explanation involving training.
- Attack the denominator. It counts visits with visit_status 'completed', while out_of_window and missed visits are excluded even though out-of-window attendance is itself a deviation in most protocols, so a site that pushes visits out of window lowers the rate twice over.
- Standardise the visit mix. Newly activated sites contribute mostly screening and baseline visits, which carry fewer procedures and fewer opportunities to deviate than later treatment visits, so compute the rate within visit_number strata and reweight to a fixed mix before comparing months.
- Split major from minor deviation_severity and report them separately. A single major deviation can remove a subject from the per-protocol analysis set while ten minor ones may not, so a pooled rate can fall while the consequential series rises.
- Before attributing anything to training, model at the right level: subjects are nested in sites, so use a random intercept per site or cluster-robust standard errors. With average cluster size m and intracluster correlation rho the variance is understated by the design effect 1 + (m - 1) times rho, which at m = 60 and rho = 0.02 is about 2.2, so naive intervals are roughly 1.5 times too narrow.
Follow-up
- Design a defensible evaluation of the retraining rollout, given it was deployed site by site and cannot be withheld.
- Your reweighted series is flat but major deviations rose. What do you escalate and to whom?
- How would you decide the holdback period, and how would you communicate a provisional number without it being quoted as final?
Four days spend equal time on query work, statistics, modelling and product judgement at deliberately shallow depth, which produces a scored map of where you actually stand. The last three days spend everything on the two areas the role weights most, and close by re-running day one to measure movement.
Prepare, practise & reflect
One practical outcome each day. Spend longer where you need it.
0 / 7 done01Breadth pass: query fluency
- Solve six prompts spanning aggregation, joins, window functions and date arithmetic in 60 minutes total, stopping at 10 minutes each whether or not it works, and mark every prompt as solved, solved slowly, or stuck.
- For each unsolved prompt write the single blocking sentence (I lost the grain, I did not know the frame clause, I could not express the date boundary) instead of reading the solution.
- Translate one pandas transformation you know well into SQL and one SQL query into pandas, checking that both return the same row count and the same totals.
Deliverable: A scored six-row table, one line per prompt, saved for the day-seven re-run.
Practice prompt ↗Practice prompt ↗Practice prompt ↗Worked solution ↗02Breadth pass: statistics and inference
- Answer ten short questions in writing with nothing open: what a p-value is conditional on, what a 95 percent interval covers across repeated samples, when a paired test is the right one, what the bootstrap estimates, why multiple comparisons inflate false positives, how controlling the family-wise error rate differs from controlling the false discovery rate, what power depends on, what a missed real effect costs a product, the three situations where the central limit theorem does not rescue you (small n, very heavy tails, dependent observations), and what a standard error is the standard deviation of.
- Grade yourself against a reference and count only the answers that were exactly right, not the ones that were nearly right.
- Rewrite the two weakest answers the following morning from memory in full sentences.
Deliverable: Ten graded answers with an honest count of exact hits.
Practice prompt ↗Practice prompt ↗03Breadth pass: modelling
- Take one tabular dataset end to end in 90 minutes: a leakage-safe split, a baseline that is not a model (majority class or historical mean), one regularized linear model, one gradient-boosted tree, and a single evaluation metric chosen before you look at any result.
- Write why that metric fits the cost structure: precision at a fixed recall for alerting, calibration for anything feeding a price or a threshold, ranking metrics for retrieval, and note that area under the ROC curve is insensitive to class balance in a way that can flatter a rare-positive problem.
- Name the leak you were most likely to introduce (an encoding fit on all rows before splitting, or a feature computed after the label's timestamp) and write the check that would have caught it.
Deliverable: A notebook whose first cell states the metric and the baseline, plus two lines on what beat what and by how much.
Practice prompt ↗Practice prompt ↗04Breadth pass: product judgement
- Answer three case prompts aloud at 15 minutes each, timing how long passes before you state a success metric.
- For one case write the first segmentation you would run and the row counts you expect per segment, so that a tiny segment cannot quietly drive the conclusion.
- Take a metric definition you did not write, from a public dashboard, a textbook, or documentation you already have open, and list every place two analysts implementing it would diverge: which rows the denominator admits, whether the unit is an account or a person, what the time window is anchored to, and what happens to data that arrives late. Then write the one question that would close the largest of those gaps.
Deliverable: Three recorded case answers plus an ambiguity list for a metric someone else defined, ending in the single question you would ask about it.
Practice prompt ↗Practice prompt ↗Worked solution ↗05Depth, first area
- Rank the four areas by how many bullet points in the role description each one covers, pick the top one, and spend the entire day inside it.
- Work the six hardest problems you can find in that area and for each write the generalizable move you should have reached for first, rather than the answer.
- Re-solve the two you failed the same evening with notes closed.
Deliverable: Six generalizable moves written as instructions to yourself, not as solutions.
Practice prompt ↗Practice prompt ↗06Depth, second area, and the seam between them
- Repeat the depth protocol on the second-ranked area with the same six-problem structure.
- Construct one problem that requires both areas at once, for example a metric redefinition whose effect you must validate with a test whose readout you then have to query.
- Solve your own combined problem end to end and note where the handoff between the two areas cost you time.
Deliverable: One combined problem, solved end to end, with the handoff failure written down.
Practice prompt ↗Practice prompt ↗07Integration and re-measurement
- Re-run the six prompts from day one under the same clock and compare both correctness and time.
- Run a 60-minute mixed mock that moves between areas without warning, since switching cost is what breadth passes do not train.
- Write the two areas you would still fail on, and the sentence you will use in the interview when you hit one of them.
Deliverable: A before-and-after score table plus a written plan for the two remaining gaps.
Practice prompt ↗Practice prompt ↗Worked solution ↗Expand any day for tasks and deliverables. Your progress is saved on this device.
A number you shipped turned out to be wrong, and someone had already acted on it. That is one of the most useful stories a data person can carry. What is being scored is how fast you noticed, who you told first, and what you changed in the process so the same class of error could not repeat quietly.
How do you explain the difference between supervised and unsupervised …
How do you explain the difference between supervised and unsupervised learning to a non-technical stakeholder?
Approach
- State the situation in two sentences and spend the rest on your reasoning.
- Name the disagreement or constraint, and how you resolved it with evidence.
- Close with what you would do differently, concretely.
Follow-up
- What would you do differently if you ran that project again?
- What did you decide not to do, and why?
Scope a one-line request for a readmission rate
A clinical operations lead messages you: 'What is our readmission rate? The committee meets Friday.' You have encounter (encounter_id, admit_ts, discharge_ts, encounter_type, admission_type, discharge_disposition, drg_code, index_encounter_id) and member_enrollment coverage spans. Do not open a query editor yet. Deliverable: the three to five questions you send back, ranked by how much the answer moves the number; the default specification you will build if nobody replies by Wednesday; and the one line you will place under the figure so the committee does not read it against a published benchmark.
Approach
- Read the probe: this tests whether you convert ambiguity into a specification without either stalling or guessing silently. Both failure modes are common, and the silent guess is worse because nobody can see it.
- Rank your questions by leverage on the number rather than by curiosity. Whether the numerator is all-cause or unplanned, and whether the clock starts at discharge_ts, move the result far more than a tie-break rule on same-day returns.
- Ask about the comparison first. A number going to a committee will be compared to something, and whether that something is last quarter, another panel, or a national figure decides whether you owe them a raw rate, a risk-adjusted rate, or an observed-over-expected ratio.
- Commit to a default in writing so silence does not block you: unplanned acute inpatient readmission within 30 days of discharge_ts, index stays excluding planned admissions, acute-to-acute transfers, discharges against medical advice, and dispositions of expired or hospice, denominator of eligible index discharges, paid-through date stated.
- Write the caveat as a restriction on use rather than a hedge: name the one comparison the figure supports and the one it does not.
Follow-up
- They reply that they want it 'the way the benchmark does it'. What do you ask next?
- The committee wants it split by attending provider. What changes in the specification, and what do you refuse to show?
- How does your answer change if the meeting is tomorrow rather than Friday?
Disagree with a product manager about an adherence nudge
A product manager proposes shipping a refill-reminder feature to the whole member base, citing an internal analysis: members with 12-month proportion of days covered at or above 0.80 had 31 percent fewer admissions than members below it. The roadmap date is three weeks out and engineering is scoped. You believe the comparison builds survival and continuous coverage into the exposure definition, and is separately confounded by the kind of member who refills on time. Deliverable: what you say in the room, what you send afterwards, and the smallest study you would accept as sufficient to ship.
Approach
- The probe is whether you can be specific and non-territorial at once. A disagreement that arrives as 'the analysis is flawed' costs you the room; one that names a mechanism and offers a cheaper path keeps it.
- Name the two defects separately, because they have different fixes. Classifying a member as adherent over 12 months requires them to stay alive and stay covered for those 12 months, and that guaranteed event-free interval is assigned to the adherent group. Separately, members who refill on schedule differ from those who do not in ways claims never record.
- Show rather than assert. Rerun the same comparison as a landmark analysis: classify adherence over days 1 to 90, start follow-up at day 91 for everyone still enrolled and event-free, and report how much of the 31 percent survives.
- Separate the association claim from the intervention claim out loud. Nothing in the analysis speaks to whether a reminder changes refill behaviour, which is the actual product question and is separately testable.
- Offer the shippable path: a randomised holdout on a subset with proportion of days covered as the primary endpoint, powered on the plausible effect of a reminder rather than on the 31 percent, with a stated read date.
Follow-up
- The landmark rerun still shows a 20 percent difference. Do you ship?
- The product manager says a holdout delays launch. How do you cost that argument?
- What primary endpoint do you choose, and why not admissions?
- 01
How do you explain the difference between supervised and unsupervised learning to a non-technical stakeholder?
- 02
A clinical operations lead messages you: 'What is our readmission rate? The committee meets Friday.' You have encounter (encounter_id, admit_ts, discharge_ts, encounter_type, admission_type, discharge_disposition, drg_code, index_encounter_id) and member_enrollment coverage spans. Do not open a query editor yet. Deliverable: the three to five questions you send back, ranked by how much the answer moves the number; the default specification you will build if nobody replies by Wednesday; and the one line you will place under the figure so the committee does not read it against a published benchmark.
- 03
A product manager proposes shipping a refill-reminder feature to the whole member base, citing an internal analysis: members with 12-month proportion of days covered at or above 0.80 had 31 percent fewer admissions than members below it. The roadmap date is three weeks out and engineering is scoped. You believe the comparison builds survival and continuous coverage into the exposure definition, and is separately confounded by the kind of member who refills on time. Deliverable: what you say in the room, what you send afterwards, and the smallest study you would accept as sufficient to ship.
Is this an official J&B Medical Supply interview guide?
No. It is PracHub's own research and practice material for the Data Scientist role at J&B Medical Supply. Rounds and questions reflect what candidates have reported, not a process J&B Medical Supply has published, and they change over time. Confirm the current format and scope with your recruiter.
PracHub interview research ↗How difficult are the technical interviews?
The difficulty is generally moderate. Candidates report that the interviews focus on practical, real-world application rather than "trick" questions or obscure algorithm puzzles.
PracHub interview research ↗What is the most common reason for failure?
Aside from technical gaps, the most common hurdle is difficulty in clearly articulating ideas. Ensure your communication is concise and structured.
PracHub interview research ↗Can I expect a case study?
Yes, case studies are a standard part of the J&B Medical Supply process and assess how you approach ambiguous business problems.
PracHub interview research ↗How long is the overall process?
The timeline varies, but typically spans a few weeks from the initial HR screen to the final panel interviews.
PracHub interview research ↗Sources & methodology 3 sources ↗
No official company page is cited. Rounds and questions come from candidate reports and PracHub editorial material; each source shows the date it was read.
- 01PracHub interview research ↗
PracHub editorial research into this company and role, maintained with this guide. Candidate-reported, not an employer publication.
PracHub page · Accessed 2026-09-22 - 02PracHub Data Scientist practice ↗
Cross-company practice questions for this role.
PracHub page · Accessed 2026-09-22 - 03PracHub interview preparation framework ↗
The framework the preparation plan follows.
PracHub page · Accessed 2026-09-22
Explore related engineering environments and compare the preparation focus.
Veracyte Data Scientist Interview Questions & Guide 2026
Causal-inference exercises for Veracyte data scientist prep: difference-in-differences, matching, instrumental variables, and knowing when observational data simply cannot answer the question asked.
Zoetis Data Scientist Interview Questions & Guide 2026
Metric-diagnosis practice for Zoetis data scientist candidates: a number moves week over week and you work out why, splitting by segment, ruling out a logging or release change, and separating a mix shift from a real change in user behaviou
Vizient Data Scientist Interview Questions & Guide 2026
Communication practice for Vizient data scientist candidates: turn an analysis into a recommendation, name the uncertainty honestly, and answer the follow-up a skeptical stakeholder will raise.
Vibrant Emotional Health Data Scientist Interview Questions & Guide 2026
Case practice for the Vibrant Emotional Health data scientist interview, where the prompt is deliberately underspecified and your first move is scoping it into something measurable.